In particular, studies illustrating the inhibition or genetic deletion of endogenous NOSs support a tumor-promoting role of the inducible isoform of NOS (iNOS) [5,6,7] and numerous studies have suggested a pro-tumorigenic role for NO● in gliomas [8,9]. The gene discussed is NOS2; the disease is central nervous system cancer.